1,024 material Form 8-K filings that 799 companies we cover made with the SEC in August 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Celsius closed a transaction with PepsiCo on August 28, 2025, receiving $585.0 million in cash for 390,000 shares of new Series B Convertible Preferred Stock and acquiring the Rockstar Energy brand in the U.S. and Canada. The deal also gives PepsiCo board designation rights, adds Michael Del Pozzo to the board, and sets up a distribution arrangement covering Alani Nu and Rockstar Energy products, which shareholders should weigh against the dilution and governance rights that come with the preferred stock.
Series B Preferred Stock sold to PepsiCo for $585.0 million in cash; each share is initially convertible into 11,304,348 shares of common stock
Rockstar Energy brand in the U.S. and Canada acquired from PepsiCo under a transaction agreement; the Captaincy also commenced on the Closing Date
PepsiCo may designate two board members, and Michael Del Pozzo was appointed as the second PepsiCo designee, expanding the board from nine to 10 members
Original Purchase Agreement terminated on the Closing Date, August 28, 2025
Exelixis said its board appointed Dana T. Aftab, Ph.D., currently Chief Scientific Officer, as Executive Vice President, Research and Development, effective August 29, 2025. The filing also states that Amy C. Peterson, M.D., concluded her service as Executive Vice President, Product Development and Medical Affairs and Chief Medical Officer on the same date, and that she is entitled to payments under the company's Change in Control and Severance Benefit Plan. The changes affect the company's senior research and medical leadership, and the filing does not disclose the amount of Dr. Peterson's payments.
Dana T. Aftab, Ph.D., appointed Executive Vice President, Research and Development, effective August 29, 2025
Aftab was previously Executive Vice President, Discovery and Translational Research and Chief Scientific Officer
Amy C. Peterson, M.D., concluded service as EVP, Product Development and Medical Affairs and Chief Medical Officer effective August 29, 2025
Peterson is entitled to payments under the Change in Control and Severance Benefit Plan; amounts not disclosed in the filing
Chemours Chair Dawn Farrell notified the board on August 29, 2025, that she will resign effective September 2, 2025, to become CEO of Canada's newly created Major Projects Office. The board has not yet chosen a successor as chair and said an announcement will follow, so shareholders will be watching for who leads the board.
Dawn Farrell resigns as Chair and from the Board effective September 2, 2025
Farrell is accepting appointment as CEO of the Major Projects Office launched by the Prime Minister of Canada under the Building Canada Act
No successor as Board Chair has been named; the company says an announcement will be forthcoming
Sarepta Therapeutics exchanged $700.0 million of its 1.25% convertible notes due 2027 for $602.0 million of new 4.875% convertible notes due 2030, 5,851,693 shares of common stock and about $123.3 million in cash. The new notes were issued August 28, 2025, and the company also sold 1,106,806 shares to J. Wood Capital Advisors LLC at $18.07 per share, so shareholders face a new debt obligation alongside potential dilution from share issuance and conversion.
Exchanged $700.0 million of 1.25% notes due 2027 for $602.0 million of new 4.875% notes due September 1, 2030, plus 5,851,693 shares and about $123.3 million in cash
New notes have an initial conversion price of about $60.00 per share, versus $20.58 last reported sale price on August 20, 2025
Interest is payable March 1 and September 1 each year, beginning March 1, 2026
Concurrent private placement of 1,106,806 shares to J. Wood Capital Advisors LLC at $18.07 per share
Directors Tracy A. Bolt and A. Haag Sherman resigned from Hilltop Holdings' Board of Directors effective immediately on August 27, 2025. The filing states their resignations were not the result of any disagreement with the company on its operations, policies or practices. On August 29, 2025, the board appointed J. Taylor Crandall as Lead Independent Director.
Tracy A. Bolt and A. Haag Sherman resigned from the board on August 27, 2025, effective immediately
The filing states the resignations were not due to any disagreement with the company
J. Taylor Crandall was appointed Lead Independent Director on August 29, 2025
At its August 27, 2025 annual meeting, Rocket Lab's stockholders re-elected no one new but elected three Class I directors, ratified Deloitte & Touche as auditor, and approved the executive pay advisory vote. They did not approve an amendment to remove a recently added pass-through voting provision at subsidiary Rocket Lab USA, Inc., because it did not reach the required 66-2/3% of voting power. The company also adopted a Senior Executive Cash Incentive Bonus Plan on August 25, 2025.
Stockholders elected Jon Olson, Merline Saintil and Alex Slusky as Class I directors for terms expiring at the 2028 annual meeting.
The charter amendment for Rocket Lab USA, Inc. received 298,079,255 votes for and 1,925,556 against, short of the required 66-2/3% of voting power.
Compensation Committee adopted the Senior Executive Cash Incentive Bonus Plan on August 25, 2025; the full plan is filed as Exhibit 10.1.
Stockholders approved the named executive officer compensation on an advisory basis, with 240,340,772 votes for and 58,526,365 against.
McKinley Acquisition Corporation filed an 8-K to report that it completed its initial public offering of 15,000,000 units at $10.00 per unit, generating $150 million in gross proceeds, plus a private placement of 465,000 units. The $150 million was deposited in a trust account for public shareholders, and the auditor's report includes a going concern warning, stating that the company lacks the capital to fund operations for a reasonable period and that there is substantial doubt about its ability to continue. The company has not yet identified a business combination target and must complete one within 18 months of the IPO closing or redeem public shares.
15,000,000 units sold at $10.00 each, generating $150 million in gross proceeds; the IPO closed on August 13, 2025
465,000 private placement units sold at $10.00 each, or $4.65 million, to McKinley Partners LLC, Clear Street LLC and Brookline Capital Markets, with $500,000 not yet received
$150 million deposited in the trust account for public shareholders as of August 13, 2025; the company has 18 months to complete an initial business combination
CBIZ CPAs P.C. included a going concern explanatory paragraph in its audit report dated August 29, 2025
Greif reported fiscal third-quarter 2025 results, with net income attributable to Greif falling to $64.0 million from $87.1 million a year earlier, mainly due to a $46.1 million gain on the 2024 Delta Petroleum divestiture. Combined Adjusted EBITDA rose 11% to $220.9 million and adjusted free cash flow was $170.7 million, while the company also agreed to sell its timberlands business for $462.0 million and kept its fiscal 2025 guidance of $725 million to $735 million in Combined Adjusted EBITDA.
Net income attributable to Greif fell to $64.0 million, or $1.10 per diluted Class A share, from $87.1 million, or $1.50, a year earlier
Net income excluding adjustments rose 11.6% to $60.4 million, or $1.03 per diluted Class A share, versus $0.92 a year earlier
Combined Adjusted EBITDA rose 11% to $220.9 million; fiscal 2025 outlook is $725 million to $735 million
Agreed sale of timberlands business for $462.0 million to Molpus Woodlands Group, with closing anticipated October 1, 2025
Leggett & Platt completed the sale of its Aerospace Products Group to funds advised by Tinicum Incorporated on August 29, 2025, receiving an estimated $285.8 million in cash at closing, subject to post-closing adjustments. The company also revised its full-year 2025 guidance: sales and adjusted EPS ranges were lowered, while reported EPS ranges were raised because of a $0.60 per share gain on the sale.
Estimated purchase price of $285.8 million paid in cash at closing, subject to customary post-closing adjustments
Company expects after-tax proceeds of approximately $250 million, to be used primarily to pay down debt
2025 sales guidance revised to $3.9 billion to $4.2 billion from $4.0 billion to $4.3 billion, excluding the Aerospace Products Group
2025 adjusted EPS guidance revised to $0.95 to $1.15 from $1.00 to $1.20; reported EPS guidance raised to $1.43 to $1.72 from $0.88 to $1.17
Hope Bancorp disclosed that Steven S. Koh, its Honorary Chairman and a board member, will retire from the board. The filing says the retirement was not the result of any disagreement with the company, and the board is expected to be reduced to 10 directors afterward. The change affects board composition but does not involve the CEO, CFO or a financial result.
Steven S. Koh, Honorary Chairman, will retire from the board; the 8-K gives an effective date of December 1, 2025, while the press release gives December 31, 2025
Mr. Koh served as Honorary Chairman since July 6, 2017, and as the first Chairman of Hope Bancorp from July 29, 2016
The board is expected to be fixed at 10 directors following his retirement
The company states the decision was not the result of any disagreement on operations, policies or practices
Crocs appointed Patraic Reagan, currently CFO of SharkNinja, as Executive Vice President and Chief Financial Officer, effective September 22, 2025, after CFO Susan Healy resigned effective immediately on August 28, 2025. The company also reaffirmed its third quarter 2025 financial outlook, which it had previously disclosed on August 7, 2025.
Patraic Reagan starts September 22, 2025, with an annual base salary of $750,000 and a sign-on bonus of $800,000, which he must repay if he leaves or is terminated for Cause within 12 months.
Reagan receives a $3.5 million equity grant in time-based restricted stock units, vesting in parts from six to 36 months after his start date.
Susan Healy resigned on August 28, 2025, and will serve as Special Advisor until October 31, 2025, with a $400,000 lump sum payable on her separation date and no cash severance.
Crocs reaffirmed its third quarter 2025 outlook and will present at the Goldman Sachs 32nd Annual Global Retailing Conference on September 3, 2025.
Flanigan's Enterprises, Inc. disclosed that Chief Operating Officer and Executive Vice President Mr. Bucci gave notice on August 21, 2025 of his intended resignation from both positions, effective December 31, 2025. He has indicated he intends to remain on the Company's Board of Directors, which may provide continuity for shareholders during the transition.
Notice of resignation given on August 21, 2025
Resignation effective December 31, 2025, from Chief Operating Officer and Executive Vice President roles
Mr. Bucci intends to continue as a member of the Board of Directors
Digital Realty's board approved a 2025 Carried Interest Plan on August 27, 2025, letting certain employees, including named executive officers, earn carried interest or appreciation interest awards tied to the company's strategic capital ventures. CEO Andrew Power received a 4.5% carried interest or promote percentage and CFO Matthew Mercier received 1.5%, both granted August 27, 2025. The filing does not report financial results, but it shows how executive pay may link to returns on certain investment vehicles.
Board approved the Digital Realty 2025 Carried Interest Plan on August 27, 2025
Andrew P. Power, President and CEO, granted a 4.5% carried interest or promote percentage
Matthew Mercier, CFO, granted a 1.5% carried interest or promote percentage
Awards vest on a service condition over four years and a performance condition tied to carried interest payments; no more than 50% of distributions from any carry vehicle may go to participants
AutoZone said Executive Vice President Bill Hackney will retire effective November 7, 2025, and named Eric Gould, currently Senior Vice President, Supply Chain, as his successor effective August 25, 2025. The filing also discloses that Senior Vice President Human Resources Rick Smith will retire in January 2026, with Eric Leef joining from Hertz to succeed him. The changes affect senior management succession rather than reported financial results.
Bill Hackney, EVP Merchandising, Marketing and Supply Chain, Customer Satisfaction, retires effective November 7, 2025
Eric Gould, a 33-year AutoZone employee, appointed EVP Merchandising, Marketing and Supply Chain, effective August 25, 2025
Rick Smith, SVP Human Resources, retires in January 2026; Eric Leef, formerly EVP Human Resources at Hertz, will succeed him
Denise McCullough promoted to Senior Vice President, Supply Chain
Abercrombie & Fitch reported second-quarter fiscal 2025 net sales of $1.2 billion, up 7% from a year earlier, and raised its full-year net sales growth outlook to 5% to 7%. GAAP diluted EPS rose to $2.91 from $2.50, helped by a $39 million pre-tax litigation settlement benefit; excluding that item, adjusted EPS was $2.32, down from $2.50 a year earlier. The company also set its full-year EPS outlook at $10.00 to $10.50 and estimates about $90 million of net tariff expense.
Net sales of $1.2 billion, up 7%: Hollister brands up 19%, Abercrombie brands down 5%.
GAAP EPS $2.91 vs. $2.50 a year earlier; adjusted EPS $2.32 vs. $2.50, excluding a $0.59 per share litigation settlement benefit.
Full-year net sales growth outlook raised to 5% to 7% from 3% to 6%; full-year EPS outlook $10.00 to $10.50.
Third-quarter EPS outlook of $2.05 to $2.25; the company repurchased $50 million of shares in the quarter.
On August 28, 2025, Avnet and Avnet Holding Europe amended two credit agreements, temporarily raising the maximum consolidated leverage ratio from 4.00 to 1.00 to 5.00 to 1.00 for periods ending around September 30, 2025 through March 31, 2026. During this relief period, Avnet is restricted from certain restricted payments, but it may keep paying cash dividends at no higher amount or frequency and may repurchase up to $100 million of common stock, which gives shareholders a clearer view of the limits on capital returns while the covenant is loosened.
Maximum leverage ratio raised from 4.00 to 1.00 to 5.00 to 1.00 for four-quarter periods ending around September 30, 2025 through March 31, 2026
Ratio steps down to 4.50 to 1.00 for the period ending around June 30, 2026, then returns to 4.00 to 1.00 from September 30, 2026
Cash dividends may continue without increasing in amount or frequency; share repurchases capped at $100 million during the relief period
Amendments cover the Third Amended and Restated Credit Agreement dated January 17, 2025 and the Credit Agreement dated July 1, 2025, with Bank of America, N.A. as administrative agent
Goosehead Insurance appointed Chief Financial Officer Mark E. Jones, Jr. as Chief Operating Officer, effective August 26, 2025, and he will remain CFO, combining both roles. The filing says he will oversee finance, operations and go-to-market functions, and that he will receive stock options on 20,000 Class A shares, granted at a 10% premium to the closing price on the grant date.
Mark E. Jones, Jr. appointed Chief Operating Officer effective August 26, 2025, while remaining Chief Financial Officer
Role combines finance, operations and go-to-market revenue functions, per the company's August 28, 2025 press release
Stock options for 20,000 Class A shares granted at a 10% premium over the closing price on the grant date; other compensation unchanged
Jones is the son of Executive Chairman Mark E. Jones and Vice Chairman Robyn Jones
J&J Snack Foods said on August 28, 2025 that it committed to a plan to optimize its manufacturing footprint, including closing certain plants. The company expects pre-tax plant closure and asset impairment charges of $12 million to $20 million across its fiscal fourth quarter of 2025 and into fiscal 2026, and estimates about $15 million in annualized pre-tax savings once closures are complete.
Expected pre-tax charges of $12 million to $20 million, including $4 million to $8 million of non-cash asset write-downs and write-offs
Severance and benefit costs of $2 million to $3 million, and other exit and disposal costs of $6 million to $9 million
Closure activities expected to be completed in fiscal year 2026, with approximately $15 million in annualized pre-tax cost savings
Savings will be part of the previously announced transformation program
Nasdaq's Hearings Panel granted Australian Oilseeds an extension to regain compliance with its $2.5 million minimum stockholders' equity rule, and allowed its shares and warrants to keep trading on Nasdaq through September 30, 2025. The company reported $2.6 million in shareholder equity as of its July 22, 2025 hearing, but must meet the rule by the deadline and would then face a one-year panel monitor.
Nasdaq Panel decision received August 22, 2025; listing continues through September 30, 2025, subject to meeting the equity rule by that date
Minimum stockholders' equity requirement is $2.5 million under Nasdaq Listing Rule 5450(b)(1)(A)
Company reported $2.6 million in shareholder equity as of the July 22, 2025 hearing date
Company plans to maintain minimum equity by converting additional debt and increasing revenues; a one-year panel monitor applies if compliance is regained
Easterly Government Properties granted 844,000 performance-based LTIP Units on August 26, 2025 to senior management, named executive officers and non-employee directors under its 2024 Equity Incentive Plan. The awards vest only if the stock's average price reaches $33.78 to $36.03 over eight years, compared with a $22.52 baseline, so they pay out only if shareholders see substantial share price gains.
Total grant of 844,000 LTIP Units; the largest single award went to Mr. Crate at 425,000 units
Full vesting after five years requires the company's highest 20-day average stock price to reach $33.78 (75% earned) or $36.03 (100% earned) within eight years
Baseline price was $22.52, the NYSE closing price on August 25, 2025
Awards vest fully on a change in control under certain conditions, with performance conditions still applying
Cantor Equity Partners IV, Inc., a blank check company, closed its initial public offering of 45,000,000 Class A ordinary shares at $10.00 per share on August 22, 2025, generating $450 million in gross proceeds. The full $450 million was placed in a U.S.-based trust account to fund a future business combination, and shareholders may redeem their shares at the trust value when a deal is completed.
IPO of 45,000,000 Class A ordinary shares at $10.00 each, including 5,000,000 shares from partial exercise of the underwriters' over-allotment option
Sponsor Cantor EP Holdings IV, LLC bought 900,000 private placement shares for $9 million
$450 million placed in trust with Continental Stock Transfer & Trust Company as trustee; offering costs were about $8.6 million
Company has until August 22, 2027 to complete a business combination, or it must redeem public shares
Fair Isaac Corporation (FICO) said James Wehmann, its President, Scores, will retire effective September 5, 2025, to spend more time with his family and pursue personal interests. CEO William Lansing will take direct responsibility for the Scores business, and the filing describes the business as being on solid footing. The change is a senior executive departure in a key business line, but the filing gives no financial impact.
James Wehmann, President, Scores, retires effective September 5, 2025
Wehmann joined FICO in 2012 and held leadership roles of increasing responsibility
CEO William Lansing will have direct responsibility for the Scores business
Ingredion entered into a new five-year, $1.0 billion unsecured revolving credit facility dated August 27, 2025, with JPMorgan Chase Bank, N.A. and J.P. Morgan SE as administrative agent. The new agreement replaced the company's previous facility from June 30, 2021, which was terminated on the same date; that facility would otherwise have matured June 30, 2026. No loans had been drawn under the new facility as of its effective date, so it adds borrowing capacity rather than new debt.
Five-year unsecured revolving facility of $1.0 billion, maturing August 27, 2030
No loans drawn as of the effective date; up to $750 million of incremental commitments may be requested
Covenants require a maximum leverage ratio of 3.5 to 1.0 and minimum interest coverage of 3.5 to 1.0
Previous credit agreement dated June 30, 2021 was terminated August 27, 2025
Weyerhaeuser's subsidiary Weyerhaeuser NR Company borrowed $800 million under a term loan dated August 25, 2025, with Weyerhaeuser guaranteeing the loan. About $500 million of the proceeds was used to partly redeem the company's 4.75% notes due 2026, leaving $250 million of those notes outstanding. The filing does not report revenue, profit, or guidance, so the shareholder effect is a refinancing of existing debt.
Term loans of $800 million mature on the third anniversary of funding, with floating rates swapped to fixed for the full amount, an effective rate of 4.31%.
About $500 million of proceeds redeemed 4.75% notes due 2026 on August 25, 2025, at a make-whole price.
Remaining loan proceeds are intended for general corporate purposes; $250 million of the 2026 notes remain outstanding.
Covenants include a minimum adjusted shareholders' equity of $3.0 billion and a funded debt ratio of 65% or less.
Gap Inc. reported second quarter fiscal 2025 results for the period ended August 2, 2025. Net sales were flat at $3.7 billion and diluted earnings per share rose 6% to $0.57, while gross margin fell 140 basis points to 41.2%. The company reaffirmed its fiscal 2025 net sales growth outlook of 1% to 2%.
Diluted EPS of $0.57 versus $0.54 a year earlier; net income of $216 million versus $206 million
Net sales of $3.7 billion were flat year over year; comparable sales rose 1%
Gross margin of 41.2% decreased 140 basis points; operating income of $292 million was flat with $293 million a year earlier
Returned $144 million to shareholders in the quarter; board approved a third quarter fiscal 2025 dividend of $0.165 per share
Ulta Beauty reported second-quarter fiscal 2025 results for the period ended August 2, 2025, with net sales up 9.3% to $2.8 billion and diluted earnings per share up 9.1% to $5.78. The company also raised its full-year fiscal 2025 outlook, including diluted earnings per share of $23.85 to $24.30, up from $22.65 to $23.20. Operating margin declined to 12.4% from 12.9% a year earlier.
Comparable sales rose 6.7% in the quarter, compared with a 1.2% decrease a year earlier.
Net income was $260.9 million, or $5.78 per diluted share, compared with $252.6 million, or $5.30 per diluted share.
Fiscal 2025 comparable sales outlook raised to 2.5% to 3.5% from 0% to 1.5%; net sales outlook raised to $12.0 billion to $12.1 billion from $11.5 billion to $11.7 billion.
Results include Space NK since its July 10, 2025 acquisition; the company drew $289.1 million on its revolving credit facility to fund it.
Autodesk reported fiscal second-quarter revenue of $1.76 billion, up 17% from a year earlier, and GAAP diluted EPS of $1.46, up from $1.30. The company raised its full-year fiscal 2026 guidance, citing first-half strength and foreign exchange tailwinds, and said the SEC and the U.S. Attorney's Office for the Northern District of California have closed their investigations.
Revenue was $1,763 million, up 17% (18% in constant currency); billings were $1,678 million, up 36%.
GAAP diluted EPS was $1.46 versus $1.30; non-GAAP diluted EPS was $2.62, up $0.47.
Full-year fiscal 2026 revenue guidance is $7,025 million to $7,075 million; non-GAAP EPS guidance is $9.80 to $9.98.
The SEC notified the company on August 19, 2025, and the U.S. Attorney's Office notified it on August 21, 2025, that each was closing its matter.
The board of Eaton Vance Senior Income Trust appointed Scott E. Wennerholm as Chairperson for a four-year term, effective August 27, 2025. He replaces Susan J. Sutherland, who had served as acting Chairperson since August 9, 2025, after the death of the former Chairperson.
Scott E. Wennerholm appointed Chairperson of the Board effective August 27, 2025, for a term of 4 years
Replaces Susan J. Sutherland, who served as acting Chairperson since August 9, 2025
Former Chairperson passed away; the filing does not give further details
The trust's board appointed Scott E. Wennerholm as Chairperson effective August 27, 2025, for a four-year term. He replaces Susan J. Sutherland, who had served as acting Chairperson since August 9, 2025, after the former Chairperson died.
Scott E. Wennerholm appointed Chairperson effective August 27, 2025, for a term of 4 years
Replaces Susan J. Sutherland, acting Chairperson since August 9, 2025
Former Chairperson passed away; filing does not state other changes
The fund's Board of Trustees appointed Scott E. Wennerholm as Chairperson effective August 27, 2025, for a four-year term. He replaces Susan J. Sutherland, who had served as acting Chairperson since August 9, 2025, following the passing of the former Chairperson.
Appointment effective August 27, 2025, for a term of 4 years
Replaces Susan J. Sutherland, acting Chairperson since August 9, 2025
Change follows the passing of the former Chairperson
The fund's Board of Trustees appointed Scott E. Wennerholm as Chairperson effective August 27, 2025, for a four-year term. He replaces Susan J. Sutherland, who had served as acting Chairperson since August 9, 2025, after the passing of the former Chairperson.
Scott E. Wennerholm appointed Chairperson effective August 27, 2025, for a term of 4 years
Replaces Susan J. Sutherland, acting Chairperson since August 9, 2025
Change followed the passing of the former Chairperson of the Board
Filing dated August 28, 2025, signed by Deidre E. Walsh, Vice President & Chief Legal Officer
Effective August 27, 2025, the trust's Board of Trustees appointed Scott E. Wennerholm as Chairperson for a four-year term. He replaces Susan J. Sutherland, who had served as acting Chairperson since August 9, 2025, following the passing of the former Chairperson. The filing describes a board leadership change and does not address financial results or fund operations.
Scott E. Wennerholm appointed Chairperson effective August 27, 2025, for a term of 4 years
Replaces Susan J. Sutherland, acting Chairperson since August 9, 2025
Change followed the passing of the former Chairperson
The fund's Board of Trustees appointed Scott E. Wennerholm as Chairperson effective August 27, 2025, for a four-year term. He replaces Susan J. Sutherland, who had served as acting Chairperson since August 9, 2025, following the death of the former Chairperson.
Scott E. Wennerholm appointed Chairperson effective August 27, 2025, for a term of 4 years
Replaces Susan J. Sutherland, who served as acting Chairperson since August 9, 2025
Prior Chairperson passed away; the filing does not name the former Chairperson
The fund's Board of Trustees appointed Scott E. Wennerholm as Chairperson effective August 27, 2025, for a four-year term. He replaces Susan J. Sutherland, who had been acting Chairperson since August 9, 2025, after the passing of the former Chairperson.
Scott E. Wennerholm appointed Chairperson of the Board effective August 27, 2025, for a term of 4 years
Replaces Susan J. Sutherland, who served as acting Chairperson since August 9, 2025
Former Chairperson died; the filing does not name the individual
Brown-Forman reported first-quarter fiscal 2026 results for the period ended July 31, 2025, with net sales down 3% to $924 million (up 1% organic) and operating income down 7% to $260 million. Diluted earnings per share fell 13% to $0.36, and the company reaffirmed its full-year fiscal 2026 outlook for low-single-digit organic declines in net sales and operating income.
Net sales $924 million, down 3%; operating income $260 million, down 7%; diluted EPS $0.36, down 13%
Charges included $12 million in restructuring and other charges and a $19 million non-operating pension settlement charge
Full-year fiscal 2026 outlook reiterated: organic net sales and organic operating income each expected to decline in the low-single digit range
Board declared a quarterly dividend of $0.2265 per share, payable October 1, 2025, to holders of record on September 3, 2025
Ollie's Bargain Outlet reported second-quarter fiscal 2025 net sales of $679.6 million, up 17.5% from a year earlier, and diluted earnings per share of $0.99, up from $0.79. The company raised its fiscal 2025 net sales, earnings per share and comparable store sales outlook, which gives shareholders a higher expected range for the full year.
Net sales were $679.6 million for the 13 weeks ended August 2, 2025, up from $578.4 million; comparable store sales rose 5.0%.
Net income was $61.3 million, or $0.99 per diluted share, versus $49.0 million, or $0.79, a year earlier; adjusted EPS was $0.99 versus $0.78.
Fiscal 2025 adjusted EPS outlook was raised to $3.76 to $3.84 from $3.65 to $3.75; net sales outlook was raised to $2.631 billion to $2.644 billion from $2.579 billion to $2.599 billion.
The company opened 29 stores in the quarter, ending with 613 stores in 34 states, and raised its fiscal 2025 store opening target to 85 from 75.
Yum! Brands said Chris Turner, its chief financial officer since 2019, will become chief executive on October 1, 2025, succeeding David Gibbs, who is leaving the board on the same date and will stay on as an executive advisor through 2026. The board also amended the company's bylaws, eliminating the Vice Chair position and adding a Chief Legal Officer role.
Turner was appointed a director effective October 1, 2025, and takes over as CEO that day, succeeding David Gibbs.
Gibbs submitted his resignation as a director on August 22, 2025, effective October 1, 2025; the filing says it was not the result of any disagreement with the company.
Gibbs informed the board in March 2025 of his intention to retire after 36 years with the company; he will remain an executive advisor through 2026.
On August 22, 2025, the board amended the bylaws to eliminate the Vice Chair role, clarify the Chair's role, add a Chief Legal Officer role, and address shareholder nomination notices under Rule 14a-19.
Bath & Body Works reported second-quarter 2025 net sales up 1.5% to $1.549 billion, but diluted earnings per share fell to $0.30 from $0.68 a year earlier, and adjusted EPS was flat at $0.37. The company raised the low end of its full-year adjusted EPS guidance to $3.35 from $3.25 and expects a larger share repurchase, but its full-year GAAP EPS guidance of $3.28 to $3.53 is below 2024's $3.61.
Q2 net sales were $1,549 million, up from $1,526 million, while net income fell to $64 million from $152 million.
Adjusted EPS was $0.37, flat with last year; adjusted operating income was $172 million versus $183 million.
Full-year 2025 adjusted EPS guidance is $3.35 to $3.60, with the low end raised from $3.25; GAAP EPS guidance is $3.28 to $3.53 versus $3.61 in fiscal 2024.
Share repurchase expectation for 2025 rose to $400 million from $300 million; third-quarter EPS is expected at $0.37 to $0.45 versus $0.49 a year earlier.
Victoria's Secret & Co. reported second quarter 2025 net sales of $1.459 billion, up 3% and above its guidance range of $1.380 billion to $1.410 billion. Profit was lower: GAAP net income attributable to the company was $16 million, or $0.20 per diluted share, versus $32 million, or $0.40, a year earlier, and adjusted EPS was $0.33 versus $0.40. The company raised full-year net sales guidance but expects a third-quarter adjusted operating loss.
Q2 net sales $1.459 billion, up 3% from $1.417 billion; total comparable sales up 4%.
Q2 operating income $41 million vs. $62 million a year earlier; adjusted operating income $55 million vs. guidance of $15 million to $35 million.
Full-year net sales guidance raised to $6.330 billion to $6.410 billion from $6.2 billion to $6.3 billion; adjusted operating income outlook reiterated at $270 million to $320 million.
Third-quarter adjusted operating loss expected at $35 million to $55 million; adjusted net loss per share $0.55 to $0.75.
DICK'S Sporting Goods reported second-quarter results for the 13 weeks ended August 2, 2025, with net sales of $3,647 million, up 5.0%, and GAAP diluted earnings per share of $4.71 versus $4.37 a year earlier. The company raised its full-year 2025 comparable sales and earnings per share guidance, which excludes the pending Foot Locker acquisition that it expects to close on September 8, 2025. Non-GAAP diluted EPS was $4.38, roughly flat with the prior year, and cash and cash equivalents fell 27% to $1,231 million.
Q2 comparable sales rose 5.0%, against 4.5% a year earlier; GAAP diluted EPS was $4.71 versus $4.37, and non-GAAP diluted EPS was $4.38 versus $4.37.
Full-year 2025 EPS guidance raised to $13.90 to $14.50 from $13.80 to $14.40; comparable sales guidance raised to 2.0% to 3.5% from 1.0% to 3.0%.
Foot Locker acquisition expected to close September 8, 2025, with Foot Locker shareholder and regulatory approvals already received.
Quarterly dividend of $1.2125 per share declared August 27, 2025, payable September 26, 2025 to holders of record on September 12, 2025.
Best Buy reported second-quarter revenue of $9.44 billion, up from $9.29 billion a year earlier, with comparable sales rising 1.6%. Diluted EPS fell to $0.87 from $1.34, and adjusted diluted EPS was $1.28 versus $1.34, after $114 million of restructuring charges. The company kept its FY26 adjusted diluted EPS guidance of $6.15 to $6.30, so shareholders see higher sales but lower profit in the quarter.
Revenue of $9.44 billion versus $9.29 billion a year earlier; enterprise comparable sales rose 1.6% versus a 2.3% decline
Diluted EPS of $0.87 versus $1.34; adjusted diluted EPS of $1.28 versus $1.34
Restructuring charges of $114 million in Q2 FY26, including approximately $40 million of asset impairments
FY26 adjusted diluted EPS guidance of $6.15 to $6.30 reiterated; quarterly dividend of $0.95 per share payable October 9, 2025
Dollar General reported fiscal 2025 second-quarter net sales up 5.1% to $10.7 billion and diluted EPS up 9.4% to $1.86, and raised its fiscal 2025 diluted EPS guidance to $5.80 to $6.30 from $5.20 to $5.80. The board also declared a quarterly cash dividend of $0.59 per share, which matters to shareholders as a continuing cash return.
Q2 net sales rose 5.1% to $10.7 billion; same-store sales rose 2.8%
Operating profit rose 8.3% to $595.4 million; net income rose 10.0% to $411.4 million
Fiscal 2025 diluted EPS guidance raised to approximately $5.80 to $6.30, from $5.20 to $5.80
Quarterly dividend of $0.59 per share payable on or before October 21, 2025, to holders of record on October 7, 2025
Burlington Stores reported second-quarter fiscal 2025 total sales up 10% to $2.70 billion and GAAP net income of $94 million, or $1.47 per diluted share, versus $1.15 a year earlier. The company raised its full-year adjusted EPS guidance to $9.19 to $9.59, up from $8.35 in fiscal 2024, while keeping its third- and fourth-quarter comparable store sales outlook at 0% to 2%.
Q2 total sales rose 10% to $2,701 million; comparable store sales rose 5%
GAAP diluted EPS was $1.47 vs. $1.15; the company reported adjusted EPS of $1.72, up 39%, excluding bankruptcy acquired lease expenses
Full-year fiscal 2025 adjusted EPS guidance raised to $9.19 to $9.59; third-quarter adjusted EPS guidance is $1.50 to $1.60 vs. $1.55 last year
Merchandise inventories rose 16% to $1,415 million, while comparable store inventories fell 8%
Hormel Foods reported third-quarter fiscal 2025 results, with net sales up 4.6% to $3.03 billion while adjusted diluted EPS fell to $0.35 from $0.37 a year earlier. Management said commodity input costs were the largest contributor to the earnings shortfall and expects profit recovery to lag into next year, which matters to shareholders because profit is under pressure even as sales grow.
Net sales were $3.03 billion, up 4.6%; GAAP diluted EPS was $0.33 versus $0.32, and adjusted diluted EPS was $0.35 versus $0.37.
Operating income was $240 million, and adjusted operating income was $254 million, compared with $267 million a year earlier.
Fourth-quarter outlook calls for net sales of $3.15 billion to $3.25 billion and adjusted diluted EPS of $0.38 to $0.40.
Interim CEO Jeff Ettinger said the company fell short of its expectations and is taking targeted pricing actions to address commodity inflation.
V.F. Corporation entered a new $1.50 billion senior secured revolving credit facility maturing August 26, 2030, and used it on August 27, 2025 to repay and terminate its previous five-year revolving credit agreement from November 2021. The filing describes the facility as a refinancing with an uncommitted option to expand it to $2.00 billion, and it does not report any change in the company's revenue or profit.
Facility size: $1.50 billion senior secured revolving credit, with termination date August 26, 2030
Accordion feature allows an increase to a maximum of $2.00 billion, at lenders' discretion and subject to conditions
Proceeds used to refinance the terminated 2021 agreement, pay fees, and fund working capital and general corporate purposes
Interest margins range from 0.50% to 2.00% depending on the rate type and availability; commitment fee is 0.25% to 0.375%
Phibro Animal Health reported fiscal fourth-quarter and full-year results for the year ended June 30, 2025, with net sales of $1,296.2 million (up 27%) and net income of $48.3 million (up from $2.4 million). The company also issued fiscal 2026 guidance calling for net sales of $1.43 billion to $1.48 billion and net income of $73 million to $83 million, and the results and guidance were released in a press release furnished as Exhibit 99.1.
Q4 net sales were $378.7 million, up 39%, and diluted EPS was $0.42 versus $0.02 a year earlier.
Full-year diluted EPS was $1.19, up $1.13, and adjusted diluted EPS was $2.09, up 76%.
FY2026 guidance includes adjusted EBITDA of $225 million to $235 million and diluted EPS of $1.79 to $2.03.
Management said higher SG&A reflected investments in scaling operations, and gross leverage was 3.1x as of June 30, 2025.
InvenTrust Properties amended its $400 million unsecured term loans and a revolving credit agreement on August 25, 2025, extending maturities and modifying interest rates tied to its leverage ratio. Management said the weighted average maturity rises from 2.9 to 5.1 years, which the company says provides more certainty around its capital structure.
Tranche A-1 ($200 million) now matures August 26, 2030; Tranche A-2 ($200 million) matures February 24, 2031
Margins range from 115 to 160 basis points on SOFR loans, based on the company's leverage ratio
Forward-starting swaps set all-in weighted average fixed rates of 4.50% and 4.58% for the two tranches
Revolving facility amendment removes the credit spread adjustment to SOFR
Cardinal Health completed a $1 billion public offering of two note series, $600 million due 2030 and $400 million due 2035, with proceeds intended to fund part of the price of its proposed Solaris Health acquisition. If the deal is not completed by the End Date, or the company decides not to pursue it, the notes must be redeemed at 101% of principal plus accrued interest.
$600 million of 4.500% notes due 2030 and $400 million of 5.150% notes due 2035 were sold on August 27, 2025.
Net proceeds are intended to fund part of the consideration and fees for the proposed Solaris Health acquisition.
The acquisition must close by the later of August 12, 2026 or a later extended date, or the notes face special mandatory redemption at 101% of principal plus accrued interest.
Proceeds will not be placed in escrow and no security interest is required.
Cencora's board appointed director D. Mark Durcan as Chairman, effective October 1, 2025, succeeding Steven H. Collis, who is retiring as Executive Chairman and as a director at the end of the fiscal year ending September 30, 2025. The filing says Collis's retirement was not due to any disagreement with the company on its operations, policies or practices, and the board will shrink from 11 to 10 directors. The filing reports no financial results, so the change is a governance and leadership update rather than a change in company performance.
D. Mark Durcan named Chairman of the Board, effective October 1, 2025
Durcan has been a director since September 2015 and Lead Independent Director since March 2023
Steven H. Collis retires as Executive Chairman and director at the end of the fiscal year ending September 30, 2025
Board size reduced from 11 to 10 directors upon Collis's retirement
Jack Henry & Associates expanded its board from nine to 10 directors on August 22, 2025, and appointed President and CEO Greg Adelson to fill the new seat. Adelson will keep his executive roles and is not an independent director, so the change adds an insider to the board without a separate board seat fee or committee role.
Board appointed Adelson on August 22, 2025, to fill the seat created by the expansion from nine to 10 directors.
Adelson has been CEO since July 1, 2024, and President since January 25, 2022, and will keep both roles.
He is not independent under Nasdaq and SEC rules, will not serve on any board committee, and will receive no separate board compensation.
The company expects Adelson and the other nine directors to stand for reelection at the 2025 Annual Meeting of Stockholders.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.